Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk

February 25, 2013 updated by: Hillel Yaffe Medical Center

Many medicinal effects of Pomegranate juices are already known. Mainly known for its anti-viral, anti-bacterial and anti-oxide tendency of pomegranate juice.

Many studies which have demonstrated antioxidant activity of pomegranate juice in the blood and blood cells were published.

In addition, published studies have demonstrated the anti-oxidant activity which inhibit the development of atherosclerosis and stroke, even in patients with diabetes, and its effect of decreasing systolic blood pressure in patients with systemic hypertension.

The purpose of the work is to examine the effect of drinking pomegranate juice on the level of anti-oxidants in human breast milk.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

the effect of pomegranate juice consumption on breast milk anti oxidants level.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 45 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • lactating woman

Exclusion Criteria:

  • pomegranate allergy
  • diabetes mellitus
  • use of other Dietary Supplement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 2
label I- 200 cc pomegranate juice once daily for 6 weeks post partum. label II- control group, no placebo is givening.
Dietary supplement: pomegranate juice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
anti oxidant level in human breast milk
Time Frame: at least one year
at least one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hillel Yaffe Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (ANTICIPATED)

April 1, 2015

Study Registration Dates

First Submitted

February 19, 2013

First Submitted That Met QC Criteria

February 25, 2013

First Posted (ESTIMATE)

February 27, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

February 27, 2013

Last Update Submitted That Met QC Criteria

February 25, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 0013-13

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Milk

Clinical Trials on pomegranate juice

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe